Related Experiment Videos
Updated in vivo methods for evaluating topical antimicrobial agents on human skin
The Journal of Investigative Dermatology
|April 1, 1979
Summary
Updated in vivo quantitative testing procedures evaluate topical antimicrobial efficacy. These methods assess an agent's ability to prevent microbial growth, suppress dense populations, and maintain antimicrobial effects on skin over time.
Area of Science:
- Microbiology
- Dermatology
- Pharmacology
Background:
- Topical antimicrobial agents require robust efficacy testing.
- Standardized in vivo quantitative methods are crucial for evaluating these agents.
- Assessing antimicrobial performance under various conditions is essential.
Purpose of the Study:
- To present updated and expanded in vivo quantitative testing procedures.
- To determine the efficacy of topical antimicrobial agents.
- To provide reliable methods for evaluating antimicrobial performance on skin.
Main Methods:
- Occlusion test: Measures prevention of microflora expansion under occlusive dressings (24-48 hr).
- Expanded flora test: Assesses suppression of dense microbial populations (6-48 hr or 10 min).
- Persistence test: Evaluates sustained antimicrobial effect and skin reservoir establishment (up to 3 days).
- Ecological shift test: Determines alterations in cutaneous microbial ecology.
- Serum inactivation test: Assesses antimicrobial activity in the presence of serum proteins.
Main Results:
- The described methods provide quantitative data on antimicrobial efficacy.
- Testing procedures are adaptable for agents with different intended uses (e.g., immediate degerming vs. sustained effect).
- The methods allow for assessment of antimicrobial activity under various relevant conditions, including serum presence.
Conclusions:
- The presented in vivo quantitative testing procedures offer a comprehensive framework for evaluating topical antimicrobial agents.
- These updated methods enhance the reliability and scope of efficacy assessments.
- The procedures are valuable for research and development of new antimicrobial products.